State of Manufacturing Tour Day 4 Wrap: Timmons and NAM Team Take on Philadelphia to Talk Health Care and Innovation

NAM President and CEO Jay Timmons and the NAM team stopped in Philadelphia, Pa., on the fourth day of the State of Manufacturing Tour. On a day focused on innovation and changing perceptions on manufacturing, Timmons gave his address at the state-of-the-art GlaxoSmithKline (GSK) facility in Philadelphia.

At the event, co-hosted by The Pennsylvania Manufacturers’ Association (PMA) and GSK, health care and innovation were at the center of the conversation. Timmons was joined by David N. Taylor, PMA president, and Jack Bailey, GSK president of U.S. pharmaceuticals, two manufacturing champions.

GSKBlog1 Highlights from the address on health care:
“It’s an issue that has become so riven by political discord, we are losing sight of our end goal…giving workers and families affordable access to high-quality health care to keep them well. This is something the NAM cares deeply about. NAM members offer employee health insurance coverage at a higher rate than other industries. In fact, 97 percent of companies supply it. Now part of the challenge is making sure we prescribe the right medicine for health care. Here at GlaxoSmithKline, you understand matching the intervention to the patient. When treatments rely on our own genes to spark the right immunological response…well, it doesn’t get more individualized than that. Personalized treatment is the trend in medicine. On the policy front, however, there’s some movement in the opposite direction—away from the individually tailored and toward the one size fits all.”

GSK Blog 2

Highlights from the address on innovation:

“Manufacturers account for more than three-fourths of private-sector R&D. We’ve been awarded more patents than any other industry. To secure our competititiveness, we must respond with a policy environment designed to attract and retain investment…and with strong protections of intellectual property.

“We must be vigilant and push back on aggressive state legislatures that want to require pharmaceutical manufacturers to turn over and reveal highly sensitive operational information—such as pricing on specific products, marketing costs, research investments and funding streams that support new product development. It’s a misguided effort that will sap innovation, and it’s of great concern. No manufacturer should have to provide an unprecedented view of proprietary operations or its most sensitive information.

“Manufacturers will not accept this, nor will we sit quietly. Intellectual property rights must also be a central issue in trade agreements. As we work to open new markets, we cannot allow our hard-won innovations to be appropriated by our competitors. And as we champion the Internet of Things, we’ll need to modernize our communications laws to fit this new era and find new ways for ensuring our cybersecurity.”

To read the full address, check out the President’s Blog.

Timmons and the team also toured the Philadelphia Distillery and spoke with employees about the challenges of being a small manufacturer and what they want to see from Washington.

Highlights from the tour:

PD BlogF

U.S. Rep. Pat Meehan, who represents Pennslyvania’s 7th District, sent us a video since he is in Washington, D.C., for votes and work. Rep. Meehan discusses how manufacturers in Pennsylvania are thriving.

Joint Op-Ed in Today’s Philadelphia InquirerMuch Debate but Few Solutions on Health Care
By David N. Taylor, PMA president, and Jay Timmons, NAM president and CEO

“If you feel like the health-care debate has grown stale, know you’re not alone. Despite the many presidential candidates vying to lead this nation, we are hearing little new on the topic. Vitriol and political discord continue to bar us from identifying solutions to control costs, fuel innovation, preserve the employer-based health-care system and take care of workers and their families.

“This matters to Pennsylvania, where health care is an issue not just for families but also for manufacturing. As a home to many pharmaceutical leaders and medical-technology innovators, the Keystone State is on the leading edge of medical manufacturing.”

To read the full op-ed, check it out here.

Social Media Wrap on Philadelphia:

We came to Philadelphia with big expectations, and the City of Brotherly Love did not disappoint. Check out the highlights from our social media efforts and don’t forget to follow @shopfloorNAM on Twitter and Shopfloor on Facebook for the latest updates from the road.


Don’t forget ShopFloor is on Instagram with daily updates from the NAM’s Erin Streeter. Follow us @shopfloorNAM.

Check out this message from the road of the #StateofMFG Tour. #WeAreMFG

A video posted by shopfloornam (@shopfloornam) on

And the NAM is on Vine with a behind-the-scenes look at the tour.

Want to keep in touch with the NAM as we continue on the 2016 State of Manufacturing Tour? Follow us on Facebook, Twitter @shopfloorNAM and online at and share your tweets and pics with #StateofMFG and #WeAreMFG.

Mallory Micetich

Mallory Micetich

Director or Media Relations at National Association of Manufacturers
Mallory Micetich is the Director or Media Relations at the National Association of Manufacturers (NAM), the nation’s largest industrial trade association and the leading voice for the manufacturing sector in the United States. She is responsible for coordinating media strategy and communications to promote the NAM’s policy agenda. Ms. Micetich specifically focuses on media relating to the following policy areas: Energy and Resources Policy, Human Resources Policy, which includes key topics like immigration, healthcare and workforce issues, Infrastructure Policy and Regulatory Reform. Ms. Micetich also coordinates media for the Manufacturer’s Center for Legal Action.
Mallory Micetich

Leave a Reply